Spots Global Cancer Trial Database for single dose
Every month we try and update this database with for single dose cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | NCT05002140 | Metastasis Locally Advance... Recurrent Cance... | XRD-0394 Palliative radi... | 18 Years - | XRad Therapeutics Inc | |
Effect of Rifampin on the Pharmacokinetics of BAY73-4506 | NCT01322438 | Neoplasms | Regorafenib (BA... | 18 Years - 45 Years | Bayer | |
Effect of Rifampin on the Pharmacokinetics of BAY73-4506 | NCT01322438 | Neoplasms | Regorafenib (BA... | 18 Years - 45 Years | Bayer | |
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | NCT05002140 | Metastasis Locally Advance... Recurrent Cance... | XRD-0394 Palliative radi... | 18 Years - | XRad Therapeutics Inc | |
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | NCT05002140 | Metastasis Locally Advance... Recurrent Cance... | XRD-0394 Palliative radi... | 18 Years - | XRad Therapeutics Inc |